New obesity drugs are posting surgical-scale weight-loss numbers. Is the gap closing, or are we mistaking early results for the final answer?

Qure may seek approval in the UK first while in talks with the FDA about its request for a larger, sham-controlled trial of ...

Prior authorization remains a major barrier to biologic access in AD. Dr Chuck Vega covers denial rates, appeal outcomes, and the clinical data that make the fight worthwhile.

Researchers report the 5-year survival outcomes with lisocabtagene maraleucel in heavily pretreated patients with relapsed or ...

From steam injections to drug-coated balloons, the options for treating an enlarged prostate are growing fast.

Committee for Medicinal Products for Human Use (CHMP) will be conducting a review of Rifadin 20 mg/ml oral suspension and ...

New discussion around Parkinson’s treatment is putting dopamine agonists under the spotlight, with clinicians balancing motor ...

They also are conducting studies to better understand risks to patients from insects in medical settings. The presence of bed ...

In patients with ulcerative colitis exposed to anti-TNF therapy, tofacitinib is linked to higher rates of clinical and ...

Fear, withdrawal symptoms, and a lack of professional support are common barriers to detoxification from opioid substitution ...

Dr Daskalakis explains revisions to the government budget rules that could have long-term impacts on scientific funding.

Updated WHO guidance urges clinicians and health systems to identify vulnerable individuals early and strengthen prevention ...